Skip to main content
TipRanks
Go Ultimate75% OFF

Keros Therapeutics (KROS) Ratios

371 Followers

Keros Therapeutics Ratios

KROS's free cash flow for Q3 2026 was $3.33M. For the 2026 fiscal year, KROS's free cash flow was decreased by $-59.00K and operating cash flow was $3.39M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio15.4521.4514.2517.2721.23
Quick Ratio15.4521.4514.2517.2721.23
Cash Ratio14.0820.4013.5916.8619.42
Solvency Ratio2.54-4.20-4.02-3.54-4.83
Operating Cash Flow Ratio5.27-5.86-5.11-4.23-5.25
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 280.55M$ 544.56M$ 309.48M$ 256.41M$ 239.36M
Leverage Ratios
Debt-to-Assets Ratio0.050.030.040.040.00
Debt-to-Equity Ratio0.060.030.040.050.00
Debt-to-Capital Ratio0.050.030.040.050.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.121.081.111.111.05
Debt Service Coverage Ratio0.000.000.00-104004.00-14590.50
Interest Coverage Ratio0.000.000.00-114790.00-14093.25
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.450.500.490.530.05
Net Debt to EBITDA-2.902.912.082.564.06
Profitability Margins
Gross Profit Margin99.38%100.00%100.00%0.00%100.00%
EBIT Margin37.65%-5269.10%-101319.21%0.00%-282.23%
EBITDA Margin38.27%-5234.48%-100779.47%0.00%-280.35%
Operating Profit Margin28.94%-5938.96%-112543.71%0.00%-280.46%
Pretax Profit Margin37.65%-5269.10%-101319.21%0.00%-282.25%
Net Profit Margin35.65%-5277.55%-101319.21%0.00%-292.26%
Continuous Operations Profit Margin35.65%-5277.55%-101319.21%0.00%-292.26%
Net Income Per EBT94.69%100.16%100.00%100.00%103.54%
EBT Per EBIT130.12%88.72%90.03%91.19%100.64%
Return on Assets (ROA)25.74%-30.42%-41.35%-34.12%-23.01%
Return on Equity (ROE)28.70%-32.78%-46.05%-37.73%-24.16%
Return on Capital Employed (ROCE)22.24%-35.83%-49.17%-39.55%-23.16%
Return on Invested Capital (ROIC)20.90%-35.71%-49.02%-39.49%-23.08%
Return on Tangible Assets25.74%-30.42%-41.35%-34.12%-23.01%
Earnings Yield11.48%-31.61%-13.07%-8.64%-4.30%
Efficiency Ratios
Receivables Turnover38.300.800.140.001.10
Payables Turnover0.770.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover11.550.150.010.008.37
Asset Turnover0.720.010.000.000.08
Working Capital Turnover Ratio0.570.010.000.000.08
Cash Conversion Cycle-466.25458.152637.190.00330.44
Days of Sales Outstanding9.53458.152637.190.00330.44
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding475.780.000.000.000.00
Operating Cycle9.53458.152637.190.00330.44
Cash Flow Ratios
Operating Cash Flow Per Share2.89-4.30-4.23-2.78-2.66
Free Cash Flow Per Share2.85-4.35-4.31-2.82-2.71
Dividend Paid and CapEx Coverage Ratio69.31-83.31-50.53-56.46-60.69
Capital Expenditure Coverage Ratio69.31-83.31-50.53-56.46-60.69
Operating Cash Flow Coverage Ratio6.37-8.53-8.62-5.28-56.86
Operating Cash Flow to Sales Ratio0.44-45.32-824.560.00-3.09
Free Cash Flow Yield13.98%-27.47%-10.84%-5.88%-4.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio8.70-3.17-7.65-11.58-23.24
Price-to-Sales (P/S) Ratio3.11166.947753.760.0067.92
Price-to-Book (P/B) Ratio2.501.043.524.375.61
Price-to-Free Cash Flow (P/FCF) Ratio7.15-3.64-9.22-17.00-21.61
Price-to-Operating Cash Flow Ratio7.05-3.68-9.40-17.30-21.97
Price-to-Earnings Growth (PEG) Ratio-0.060.82-0.30-0.181.66
Enterprise Value Multiple5.22-0.28-5.61-9.10-20.17
Enterprise Value487.29M51.57M854.11M946.29M1.14B
EV to EBITDA5.22-0.28-5.61-9.10-20.17
EV to Sales2.0014.535656.390.0056.53
EV to Free Cash Flow4.60-0.32-6.73-13.27-17.99
EV to Operating Cash Flow4.53-0.32-6.86-13.51-18.28
Tangible Book Value Per Share8.1415.2711.2810.9910.42
Shareholders’ Equity Per Share8.1415.2711.2810.9910.42
Tax and Other Ratios
Effective Tax Rate0.05-0.000.000.00-0.04
Revenue Per Share6.560.090.010.000.86
Net Income Per Share2.34-5.00-5.20-4.15-2.52
Tax Burden0.951.001.001.001.04
Interest Burden1.001.001.001.001.00
Research & Development to Revenue0.5348.91895.750.002.74
SG&A to Revenue0.1911.48230.690.001.06
Stock-Based Compensation to Revenue0.129.82190.480.000.58
Income Quality1.240.860.810.671.06

Currency in USD